Ahsan Raza Raja

Mr. Ahsan Raza Raja

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2025 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
ARAhsan Raza Raja
Ahsan Raza Raja
ZFZoha Zahid Fazal
Zoha Zahid Fazal
ASAisha Sethi
Aisha Sethi

5 March 2025 in Expert Review of Respiratory Medicine
Verified
Journal Article
Closed access
ARAhsan Raza Raja
Ahsan Raza Raja
FGFareeha Faizan Ghori
Fareeha Faizan Ghori
DZDua Batool Zaide
Dua Batool Zaide
AZAli Bin Sarwar Zubairi
Ali Bin Sarwar Zubairi
Asthma remains a public health concern in the United States, with mortality disproportionately affecting demographic groups. This study aimed to describe national trends in asthma mortality from 1999 to 2020 and identify demographic and regional disparities. We retrospectively analyzed mortality data from the CDC WONDER database using International Classification of Diseases, Tenth Revision (ICD-10) codes J45 and J46. Age-adjusted mortality rates (AAMRs) were calculated by sex, race, age group, US Census region, state, and urban-rural classification. Joinpoint regression was employed to detect changes over time. A total of 82,686 asthma-related deaths were identified (37.2% males, 62.8% females). Overall, the AAMR declined from 1.72 in 1999 to 1.14 in 2020. Joinpoint analysis revealed a significant decline from 1999 to 2009, a plateau from 2009 to 2014, a further decline from 2014 to 2018, and a significant increase from 2018 to 2020. Non-Hispanic Black individuals (AAMR 2.73) and older adults (≥65 years) had the highest mortality rates, with females exhibiting higher rates than males (1.30 vs 0.95). Despite declining trends, persistent disparities in asthma mortality underscore the need for targeted interventions, improved healthcare access, and ongoing surveillance.

20 May 2025 in JGH Open
Verified
Journal Article
Open access
MNMuhammad Ahmad Nadeem
Muhammad Ahmad Nadeem
AKAbdullah Khan
Abdullah Khan
ARAhsan Raza Raja
Ahsan Raza Raja
UKUsama Hussain Kamal
Usama Hussain Kamal
AAAbdul Rafeh Awan
Abdul Rafeh Awan
ASAmir Humza Sohail
Amir Humza Sohail
Objectives: Intrahepatic cholangiocarcinoma (ICC) is a malignancy with rising incidence and mortality in the United States. This study aimed to investigate temporal trends in the place of death among patients with ICC and assess demographic disparities.Methods: We used the CDC WONDER database (2003–2020) for a retrospective study of patients who died from intrahepatic cholangiocarcinoma identified through death certificates. Place of death was categorized as hospice, home, inpatient, nursing home, or other. Age‐adjusted mortality rates were calculated per 100 000. Temporal trends were assessed using the Mann‐Kendall trend test, and associations between demographic characteristics and place of death were examined using the χ2 test.Results: Of 101 631 ICC‐related deaths (AAMR: 1.61; 95% CI 1.60–1.62), the AAMR rose from 1.19 (95% CI 1.15–1.23) in 2003 to 2.04 (95% CI 2.00–2.08) in 2020. Over the study period, home was the most frequent place of death (44.6%), followed by inpatient facilities (28.4%), hospice (11.1%), and nursing homes (9.5%). Deaths at home and in hospice increased significantly (p < 0.01), while inpatient and nursing home deaths declined (p < 0.01). Disparities were observed across race, sex, age groups, and urbanization. Younger patients more often died in inpatient facilities, and minority racial groups were less likely to die at home or utilize hospice.Conclusions: ICC‐related deaths in the USA nearly doubled over the study period, with a marked shift from inpatient and nursing home deaths to hospice and home. Demographic disparities in end‐of‐life care underscore the need for targeted interventions to improve equitable access to palliative services.

4 November 2025 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
ARAhsan Raza Raja
Ahsan Raza Raja
PCPhilippos Apolinario Costa
Philippos Apolinario Costa
MJMuhammad Hyder Junejo
Muhammad Hyder Junejo
Background: Kaposi sarcoma (KS) is an angioproliferative tumor caused by human herpesvirus 8 and is an AIDS-defining illness. Combination antiretroviral therapy (ART) was introduced in the United States in 1996, after which U.S. KS incidence declined and survival improved; however, persistent racial and sex disparities remain. Our aim was to characterize 1999–2020 trends in KS incidence and mortality in the United States overall, and by race and sex, and to quantify changes in disparities over time. Methods: We extracted KS case and death counts from the CDC WONDER database (ICD-10 codes B21.0, C46). Age-adjusted incidence rates (AAIR) and mortality rates (AAMR) per 100,000 were calculated by year, race, and sex. Temporal trends were evaluated using the Mann–Kendall test (Kendall’s τ), and between-group differences by t-test (α = 0.05). Results: From 1999 to 2020, 27,886 KS cases and 4,380 deaths occurred. Overall AAIR was 0.99 in men versus 0.10 in women, and AAMR 0.16 versus 0.01 (both p < 0.001). Black men experienced the highest AAIR (2.23) and AAMR (0.40), significantly exceeding White men (0.79 and 0.13; p < 0.001). Incidence declined in both sexes (men: -46.7%, τ = -0.920; women: -58.9%, τ = -0.848; both p < 0.001). Mortality declined in men (-66.4%, τ = -0.581; p < 0.001). Among women, AAMR levels were very low throughout (mean ≈ 0.01 per 100,000); the end-to-end change from 1999 to 2020 was + 28.6%, yet the Mann–Kendall test did not identify a monotonic trend (τ = − 0.303; p = 0.060), reflecting early declines followed by year-to-year fluctuation around a low baseline. Conclusion: Although KS incidence and mortality have declined markedly since 1999, Black men remain disproportionately affected. Focused public health efforts and enhanced access to HIV care are essential to close these gaps. Clinical trial number: Not applicable.

31 March 2026 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ARAhsan Raza Raja
Ahsan Raza Raja
ZFZoha Zahid Fazal
Zoha Zahid Fazal
ASAisha Sethi
Aisha Sethi
Background: Nonmelanoma skin cancer (NMSC) is the most common malignancy worldwide, yet the United States lacks a dedicated registry to monitor its mortality. We aimed to characterize temporal trends and demographic and regional disparities in age-adjusted NMSC mortality in the U.S. from 1999 to 2020. Methods: We conducted a retrospective analysis of CDC WONDER (Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research) database from 1999 to 2020 for NMSC. Age-adjusted mortality rates (AAMRs) per 100,000 persons and annual percent change (APC) were calculated and stratified by year, sex, race, age group, and geographic region. Results: A total of 68,223 NMSC-related deaths occurred. Overall AAMR increased from 0.845 (95% CI 0.810–0.879) in 1999 to 1.002 (0.971–1.032) in 2020. Trends showed an initial decline (1999–2004 APC − 0.7%), followed by a rise (2004–2020 APC 1.6%). Men had higher mortality than women (1.55 vs. 0.43 per 100,000), with significant increases in both sexes (men 1999–2016 APC 1.4%; women 2011–2020 APC 2.5%). NH White individuals exhibited the highest AAMR (1.03) and steepest rise (2005–2015 APC 2.8%), while NH Blacks declined (APC − 1.5%) and Hispanics increased modestly (APC 0.9%). Those ≥ 65 years had the highest AAMR (5.63). Regionally, the South (1.01) and rural areas (1.04) bore the greatest burden, with persistent increases (rural APC 1.7%; suburban APC 1.4%). Conclusions: Despite diagnostic and therapeutic advances, U.S. NMSC mortality has risen, with marked demographic and geographic disparities. Enhanced mortality surveillance, targeted prevention efforts, and equitable access to dermatologic care are needed to mitigate this growing public health burden.

26 August 2023 in OMEGA - Journal of Death and Dying
Verified
Journal Article
Closed access
SHSyed Sabih Ul Hassan
Syed Sabih Ul Hassan
WAWajid Ali
Wajid Ali
HKHamza Khan
Hamza Khan
ARAhsan Raza Raja
Ahsan Raza Raja
MHMurtuza Hassan
Murtuza Hassan
ALAsad Latif
Asad Latif
To determine how often care is limited at the end of life and the factors that are associated with this decision, we reviewed the medical records of all patients that passed away in the intensive care units (ICU) of Aga Khan University. We found that a majority of patients had Do-Not-Resuscitate orders in place at the time of death. Our analysis yielded 6 variables that were associated with the decision to limit care. These are patient age, sex, duration of mechanical ventilation, Glasgow Coma Scale (GCS) ≤8 at any point during ICU stay, GCS ≤8 in the first 24 hours following ICU admission, and mean arterial pressure <65 mm of Hg while on vasopressors in the first 24 hours following ICU admission. These variables require further study and should be carefully considered during end of life discussions to allow for optimal management at the end of life.